98 related articles for article (PubMed ID: 2774594)
1. [Change of blood lentinan level in patients with advanced cancers].
Yajima Y; Satoh J; Kikuchi T; Fukuda I; Toyota T; Saito H; Okabe N; Suzuki H
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2633-8. PubMed ID: 2774594
[TBL] [Abstract][Full Text] [Related]
2. Quantitative assay of lentinan in human blood with the limulus colorimetric test.
Yajima Y; Satoh J; Fukuda I; Kikuchi T; Toyota T
Tohoku J Exp Med; 1989 Feb; 157(2):145-51. PubMed ID: 2711382
[TBL] [Abstract][Full Text] [Related]
3. [Quantitative assay of lentinan in the human blood].
Yajima Y; Sato J; Goto Y
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2594-6. PubMed ID: 3619467
[No Abstract] [Full Text] [Related]
4. [Diversity of complement activation by lentinan, an antitumor polysaccharide, in gastric cancer patients].
Takeshita K; Saito N; Sato Y; Maruyama M; Sunagawa M; Habu H; Endo M
Nihon Geka Gakkai Zasshi; 1991 Jan; 92(1):5-11. PubMed ID: 2014026
[TBL] [Abstract][Full Text] [Related]
5. Individual patient based meta-analysis of lentinan for unresectable/recurrent gastric cancer.
Oba K; Kobayashi M; Matsui T; Kodera Y; Sakamoto J
Anticancer Res; 2009 Jul; 29(7):2739-45. PubMed ID: 19596954
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of superfine dispersed lentinan (beta-1,3-glucan) in patients with hepatocellular carcinoma.
Isoda N; Eguchi Y; Nukaya H; Hosho K; Suga Y; Suga T; Nakazawa S; Sugano K
Hepatogastroenterology; 2009; 56(90):437-41. PubMed ID: 19579616
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of oral administered superfine dispersed lentinan for advanced pancreatic cancer.
Shimizu K; Watanabe S; Watanabe S; Matsuda K; Suga T; Nakazawa S; Shiratori K
Hepatogastroenterology; 2009; 56(89):240-4. PubMed ID: 19453066
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of orally administered superfine dispersed lentinan (beta-1,3-glucan) for the treatment of advanced colorectal cancer.
Hazama S; Watanabe S; Ohashi M; Yagi M; Suzuki M; Matsuda K; Yamamoto T; Suga Y; Suga T; Nakazawa S; Oka M
Anticancer Res; 2009 Jul; 29(7):2611-7. PubMed ID: 19596936
[TBL] [Abstract][Full Text] [Related]
9. [Randomized study of lentinan on patients with advanced gastric and colorectal cancer. Tohoku Lentinan Study Group].
Wakui A; Kasai M; Konno K; Abe R; Kanamaru R; Takahashi K; Nakai Y; Yoshida Y; Koie H; Masuda H
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1050-9. PubMed ID: 3083785
[TBL] [Abstract][Full Text] [Related]
10. [Effects of lentinan in advanced or recurrent cases of gastric, colorectal, and breast cancer].
Taguchi T
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):387-93. PubMed ID: 6349538
[TBL] [Abstract][Full Text] [Related]
11. [Results of phase III study of lentinan].
Taguchi T; Furue H; Kimura T; Kondo T; Hattori T; Itoh I; Ogawa N
Gan To Kagaku Ryoho; 1985 Feb; 12(2):366-78. PubMed ID: 3918510
[TBL] [Abstract][Full Text] [Related]
12. Immunoregulatory effects of the antitumor polysaccharide lentinan on Th1/Th2 balance in patients with digestive cancers.
Yoshino S; Tabata T; Hazama S; Iizuka N; Yamamoto K; Hirayama M; Tangoku A; Oka M
Anticancer Res; 2000; 20(6C):4707-11. PubMed ID: 11205205
[TBL] [Abstract][Full Text] [Related]
13. Antitumor and metastasis-inhibitory activities of lentinan as an immunomodulator: an overview.
Chihara G; Hamuro J; Maeda YY; Shiio T; Suga T; Takasuka N; Sasaki T
Cancer Detect Prev Suppl; 1987; 1():423-43. PubMed ID: 3319150
[TBL] [Abstract][Full Text] [Related]
14. [TS-1/CDDP/Lentinan combination chemotherapy for inoperable advanced gastric cancer].
Nagahashi S; Suzuki H; Nishiwaki M; Okuda K; Kurosawa Y; Terada S; Sugihara T; Andou K; Hibi T
Gan To Kagaku Ryoho; 2004 Nov; 31(12):1999-2003. PubMed ID: 15570928
[TBL] [Abstract][Full Text] [Related]
15. A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group.
Nakano H; Namatame K; Nemoto H; Motohashi H; Nishiyama K; Kumada K
Hepatogastroenterology; 1999; 46(28):2662-8. PubMed ID: 10522061
[TBL] [Abstract][Full Text] [Related]
16. [TS-1 and lentinan combination immunochemotherapy for advanced or recurrent gastric cancer: a preliminary report].
Kimura Y; Iijima S; Kato T; Tsujie M; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E; Matsuura N; Kikkawa N
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1791-3. PubMed ID: 14619521
[TBL] [Abstract][Full Text] [Related]
17. A placebo-controlled trial of the immune modulator, lentinan, in HIV-positive patients: a phase I/II trial.
Gordon M; Bihari B; Goosby E; Gorter R; Greco M; Guralnik M; Mimura T; Rudinicki V; Wong R; Kaneko Y
J Med; 1998; 29(5-6):305-30. PubMed ID: 10503166
[TBL] [Abstract][Full Text] [Related]
18. [Usefulness of TS-1 and lentinan combination immunochemotherapy in advanced or recurrent gastric cancer--pilot study aiming at a randomized trial].
Kimura Y; Iijima S; Kato T; Tsujie M; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E; Kikkawa N; Matsuura N
Gan To Kagaku Ryoho; 2003 Aug; 30(8):1125-30. PubMed ID: 12938267
[TBL] [Abstract][Full Text] [Related]
19. [Modulation of anticancer effects of immunochemotherapeutic agents in various nutritional environments].
Akimoto M; Nishihira T; Mori S
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):827-33. PubMed ID: 3260467
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of lentinan on patients with stomach cancer: end point results of a four-year follow-up survey.
Taguchi T
Cancer Detect Prev Suppl; 1987; 1():333-49. PubMed ID: 3121179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
